Guidelines
par
Canadian Research Initiative in Substance Misuse (CRISM)
Date de publication
2019
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
The clinical guideline was developed to provide key clinical recommendations, as well as clinical guidance on the provision of iOAT. The documents provide an evidence-based path for practitioners to expand their medication offerings for clients with opioid use disorder beyond methadone and buprenorphine/naloxone, if appropriate for their clients.
Constatations/points à retenir
These resources provide national clinical guidelines and operational guidance for the provision of injectable opioid agonist treatment. Supplemental materials are provided and include: sample program expectations, sample patient bill of rights, sample client safety care plan, and sample treatment plan
Mots clés
Clinical guidance
Policy/Regulatory
Safer supply
About prescribers
Illegal drugs
Stimulants
Transitions in care/treatment
Injecting drugs
